1. Home
  2. ADAG vs NREF Comparison

ADAG vs NREF Comparison

Compare ADAG & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$4.01

Market Cap

260.3M

Sector

Health Care

ML Signal

HOLD

Logo NexPoint Real Estate Finance Inc.

NREF

NexPoint Real Estate Finance Inc.

HOLD

Current Price

$17.24

Market Cap

296.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADAG
NREF
Founded
2011
2019
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
260.3M
296.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ADAG
NREF
Price
$4.01
$17.24
Analyst Decision
Strong Buy
Hold
Analyst Count
4
2
Target Price
$8.25
$14.00
AVG Volume (30 Days)
290.4K
42.8K
Earning Date
04-01-2026
04-30-2026
Dividend Yield
N/A
13.95%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.47
P/E Ratio
N/A
$4.78
Revenue Growth
N/A
N/A
52 Week Low
$1.44
$12.36
52 Week High
$4.85
$18.43

Technical Indicators

Market Signals
Indicator
ADAG
NREF
Relative Strength Index (RSI) 56.54 53.48
Support Level $3.23 $16.39
Resistance Level $4.41 $17.22
Average True Range (ATR) 0.29 0.60
MACD 0.03 -0.04
Stochastic Oscillator 64.10 34.77

Price Performance

Historical Comparison
ADAG
NREF

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About NREF NexPoint Real Estate Finance Inc.

NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.

Share on Social Networks: